This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Colorado. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Christopher J Matheson
Introduction
Christopher J Matheson is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of three patents to his name, Matheson's work focuses on targeting specific pathways involved in cancer progression.
Latest Patents
Matheson's latest patents include groundbreaking work on WEE1 kinase inhibitors and methods of treating cancer using these compounds. His research presents a compound, or pharmaceutically acceptable salts or prodrugs thereof, that has the chemical structure designed to inhibit WEE1 kinase and treat cancer in a subject. Additionally, he has developed STAT3 transcription factor inhibitors and methods of using these compounds. These compounds inhibit the activity of Signal transducer and activator of transcription 3 (STAT3), providing potential treatments for cancer and other diseases.
Career Highlights
Christopher J Matheson is affiliated with the University of Colorado, where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from various forms of cancer.
Collaborations
Matheson collaborates with esteemed colleagues, including Philip Reigan and Donald S Backos, to further enhance the impact of his research. Their combined expertise contributes to the development of innovative solutions in the fight against cancer.
Conclusion
Christopher J Matheson exemplifies the spirit of innovation in the field of cancer research. His patents and collaborative efforts highlight the importance of targeted therapies in improving patient care. Through his work, Matheson continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile